CIP
BRLI

Champlain Investment Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Champlain Investment Partners’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-734,430
Closed -$21.1M – 147
2013
Q2 		$21.1M Buy
+734,430
New +$20.2M 0.43% 94

Other funds holding BRLI

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CM
CS McKee Pittsburgh, Pennsylvania $1.09B AUM 31.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Champlain Investment Partners's BRLI Position: Q3 2013 in Review

Champlain Investment Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2013, closing a stake of 734,430 shares — an estimated $21.1M sold.

Champlain Investment Partners first reported a position in BRLI in Q2 2013 and held it in 1 quarter. The position peaked at $21.1M in Q2 2013. 175 funds tracked by Wall St. Rank hold BRLI as of Q3 2013.

  • Champlain Investment Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2013 after selling out during the quarter.
  • Champlain Investment Partners sold 734,430 BIO-REFERENCE LABS INC-NEW- shares in Q3 2013, an estimated $21.1M.
  • Champlain Investment Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 1 quarter.
  • Champlain Investment Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $21.1M in Q2 2013.
  • 175 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2013.

Based on Champlain Investment Partners's 13F filing for Q3 2013, filed 12 Nov 2013.